US69404D1081
US69404D1081
Pacific Biosciences of Californ
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 160.005.000 | 154.014.000 | 3.9% |
| Cost of Revenue | 114.225.000 | 116.732.000 | 2.1% |
| Gross Profit | 45.780.000 | 37.282.000 | 22.8% |
| 603.341.000 | 327.945.000 | 84.0% | |
| Operating Income | -557.561.000 | -290.663.000 | 91.8% |
| Pretax Income | -546.058.000 | -309.535.000 | 76.4% |
| Net Income Common Stockholders | -546.376.000 | -309.851.000 | 76.3% |
| -- | -- | -- | |
| -- | -- | -- |